SCHEMBL20845571

SCHEMBL20845571

CCOC(=O)c1cc2cccc(Br)c2nc1C(OC)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.42
MAOA P21397 1/20 0.42
CYP1A2 P05177 1/20 0.40
TSHR P16473 2/20 0.40
CDC25B P30305 2/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CCR6 P51684 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CDC25A P30304 1/20 0.38
CDC25C P30307 1/20 0.38
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5214761 0.79 KDM4E (0.49) CYP1A2TSHRKDM4EALDH1A1KMT2A
SCHEMBL29076964 0.77 KDM4E (0.50) MAOBMAOACYP1A2TSHRCDC25B
SCHEMBL23432990 0.77 HTT (0.41) MAOBMAOACYP1A2TSHRKDM4E
SCHEMBL20845567 0.75 ALDH1A1 (0.49) TSHRKDM4EALDH1A1L3MBTL1HPGD
SCHEMBL30165457 0.74 KDM4E (0.52) MAOBMAOACYP1A2KDM4EALDH1A1
SCHEMBL29291542 0.72 BACE1 (0.34) ALDH1A1KMT2AHPGDNPSR1RXFP1
SCHEMBL2203246 0.72 PSMD14 (0.51) MAOBCYP1A2KDM4EKMT2AMAPK1
SCHEMBL6586612 0.71 CCR6 (0.53) CYP1A2TSHRCDC25BKDM4EALDH1A1
SCHEMBL3207023 0.70 TSHR (0.59) MAOBMAOACYP1A2TSHRCDC25B
SCHEMBL954118 0.69 TSHR (0.58) MAOBMAOACYP1A2TSHRCDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113735844-A 2-formyl quinoline carboxamide compound and medical application thereof 正大天晴药业集团股份有限公司 2021-12-03 CN disclosed
WO-2019057053-A1 FUSED RING DERIVATIVE USED AS FGFR4 INHIBITOR 北京加科思益新药研发有限公司 2019-03-28 WO disclosed